ArticleFrontiers in oncology2024

Efficacy and safety of the combination of anlotinib and envafolimab in the treatment of unresectable or metastatic liposarcoma: findings from a single-center retrospective study.

Hongliang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.